TCR Cure

About:

TCR Cure is a biopharmaceutical company that focuses on the development of tumor immune cell therapy.

Website: http://www.tcrcure.com/

Top Investors: Share Capital, Fang Fund Partners, Emerging Technology Partners, Yueyin Venture Capital, Jiadaogu Touzi

Description:

TCR Cure provides R&D and industrialization of tumor immune cell therapy technology with engineered T cells as the ultimate target. With the development of a series of CAR-T, TCR-T, CAR-NK, and TIL immune cell therapy products, the cure rate of tumors is improved, and the mortality rate, recurrence rate, and disability rate of tumors are reduced. TCR Cure is on a mission to conquer cancer and is dedicated to assisting patients and doctors in slowing and eventually curing tumors.